Jennifer Michaelson
Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 10SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 8,000158,844 held (−5%) | $21.57 | $173K | -28.0% |
| Aug 14SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 30,000162,844 held (−16%) | $20.26 | $608K | -23.3% |
| Jul 7SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 8,000162,844 held (−5%) | $17.82 | $143K | -12.9% |
| May 6SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 7,800167,044 held (−4%) | $14.60 | $114K | +6.4% |
| May 6SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 200166,844 held (−0%) | $15.58 | $3K | -0.3% |
| Mar 9SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 8,000170,844 held (−4%) | $15.68 | $125K | -1.0% |
| Feb 26SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 1,780174,844 held (−1%) | $14.14 | $25K | +9.8% |
| Feb 25SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 1,752180,225 held (−1%) | $13.99 | $25K | +11.0% |
| Feb 25SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 3,601176,624 held (−2%) | $14.47 | $52K | +7.3% |
| Feb 23SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 3,742181,977 held (−2%) | $13.62 | $51K | +14.0% |
| Feb 23SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 8,000181,977 held (−4%) | $14.30 | $114K | +8.6% |
| Feb 13SEC | CGEMCullinan Therapeutics, Inc. | Sell | 416128,219 held (−0%) | $12.03 | $5K | +29.1% |
| Jan 23SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 4,000128,635 held (−3%) | $12.30 | $49K | +26.3% |
| Dec 22SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 1,345132,635 held (−1%) | $10.01 | $13K | +55.1% |
| Dec 19SEC | CGEMCullinan Therapeutics, Inc. | Sell | 2,898133,980 held (−2%) | $9.67 | $28K | +60.6% |
| Dec 16SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 2,148137,873 held (−2%) | $12.38 | $27K | +25.4% |
| Dec 16SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 995136,878 held (−1%) | $11.90 | $12K | +30.5% |
| Nov 25SEC | CGEMCullinan Therapeutics, Inc. | Sell Plan | 4,000138,004 held (−3%) | $12.30 | $49K | +26.3% |
- Sell
Chief Scientific Officer Jennifer Michaelson sold $173K of CGEM at $21.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jennifer Michaelson sold $608K of CGEM at $20.26 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jennifer Michaelson sold $143K of CGEM at $17.82 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jennifer Michaelson sold $114K of CGEM at $14.60 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jennifer Michaelson sold $3K of CGEM at $15.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jennifer Michaelson sold $125K of CGEM at $15.68 — pre-scheduled 10b5-1 plan sale.